None listed
Conditions
Interventions
Intervention 1: In The Main Group The paitents eats one ca of vitaminE or placebo (400mg) one per day from the day of base sono till 2 month. Intervention 2: In The control group The Patients eat
Treatment - Drugs
In The Main Group The paitents eats one ca of vitaminE or placebo (400mg) one per day from the day of base sono till 2 month
In The control group The Patients eats one ca of vitaminE or placebo (400mg) one per day from the day of base sono till 2 month
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 39 Years
Inclusion criteria
Inclusion criteria: Exclusion criteria: Normal semen sample ? Normal Hystrosalpin geography ? Normal ovulation? IVF For ferst time ? Long protocole? Befor 39 years old ? Inclusion criteria: No desire for cooperation ? Sensivity to Vitamin E ? = 39 year old ?
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Quality and number of ovum and emberyo have received in each IVF cycle. Timepoint: - On day of ovum pick up and emberyo insercion (IVF). Method of measurement: - Measuring number and quality of ovumes on the day of pick up in lab by pathologist under microscope (GV , MI , MII ) and quality of emberyo also by the same pathologist due to kind of cell division ( Grade I , II , III , IV). | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy or misscariage. Timepoint: 4 – 6 weeks after emberyo transfering. Method of measurement: Serum BHCG and TVS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Zahra Mosallanezhad
Shiraz University of Medical Sciences
Outcome results
None listed